Press release
Non-Alcoholic Steatohepatitis (NASH) Market Analysis 2023: Market Growth Rate, Competitive Landscape And Top Opportunities
The Business Research Company's Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2023 identifies obesity as the major driver for the Non-Alcoholic Steatohepatitis (NASH) market's growth in the forecast period. Obesity is an aberrant or excessive fat build-up that poses a health concern, as well as body weight that is higher than what is deemed healthy or typical for a person of a specific height. As nonalcoholic fatty liver disease has become more prevalent due to the rising obesity pandemic, NASH may become the most widespread cause of severe liver disease in the ensuing decades, therefore, driving need for NASH treatment and related drugs.
the global non alcoholic steatohepatitis (NASH) market is expected to grow from $2.42 billion in 2022 to $3.25 billion in 2023 at a compound annual growth rate (CAGR) of 34.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global non alcoholic steatohepatitis (NASH) market is expected to grow to $10.73 billion in 2027 at a CAGR of 34.7%.
Download Free Sample Of Non-Alcoholic Steatohepatitis (NASH) Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=8805&type=smp
Major competitors in the Non-Alcoholic Steatohepatitis (NASH) market are AstraZeneca plc., Arena Pharmaceuticals Inc., GSK plc., Novo Nordisk A/S, F. Hoffmann-La Roche AG.
A key trend in the Non-Alcoholic Steatohepatitis (NASH) market includes technological advancement. Major players in the non-alcoholic steatohepatitis (NASH) market are focused on technological advancement to sustain their marketplace. For instance, in May 2021, GENFIT Inc., a France-based biotechnology company launched NASHnext, a brand-new non-invasive test for diagnosing non-alcoholic steatohepatitis (NASH). NIS4TM, a GENFIT-exclusive screening technology that uses a revolutionary blood-based molecular biomarker test to detect NASH and severe fibrosis, powers NASHnext. The test is only made available in the United States and Canada by Labcorp, one of the top worldwide life sciences businesses.
Read More On The Global Non-Alcoholic Steatohepatitis (NASH) Market Report Here:
https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-nash-global-market-report
The Non-Alcoholic Steatohepatitis (NASH) market is segmented -
• By Type: Solid, Liquid
• By Product: Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products
• By Disease Cause: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
• By Sales Channel: Hospital Pharmacy, Retail Pharmacy, Online Provider
• By Application: Oral, Parenteral
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Non-Alcoholic Steatohepatitis (NASH) market.
The Business Research Company's "Global Non-Alcoholic Steatohepatitis (NASH) Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Non-Alcoholic Steatohepatitis (NASH) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8805
The Table Of Content For The Non-Alcoholic Steatohepatitis (NASH) Market Include:
1. Executive Summary
2. Non Alcoholic Steatohepatitis (NASH) Market Characteristics
3. Non Alcoholic Steatohepatitis (NASH) Market Trends And Strategies
4. Non Alcoholic Steatohepatitis (NASH) Market - Macro Economic Scenario
5. Non Alcoholic Steatohepatitis (NASH) Market Size And Growth
……
26. Africa Non Alcoholic Steatohepatitis (NASH) Market
27. Non Alcoholic Steatohepatitis (NASH) Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Non Alcoholic Steatohepatitis (NASH) Market
29. Non Alcoholic Steatohepatitis (NASH) Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis (NASH) Market Analysis 2023: Market Growth Rate, Competitive Landscape And Top Opportunities here
News-ID: 3287669 • Views: …
More Releases from The Business research company
Comprehensive Floor Underlayment And Padding Market Forecast 2025-2034: Growth T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Floor Underlayment And Padding Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for floor underlayment and padding has seen substantial growth in recent times. The market value is projected to increase from $16.63 billion in 2024 to $17.94 billion in 2025, with…
Increasing Cybersecurity Threats In Financial Services Driving Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Fintech Crisis Management Market Size By 2025?
The dimension of the fintech crisis management market has seen swift expansion in the last few years. The market is estimated to scale from $9.38 billion in 2024 to $10.83 billion in 2025, yielding a compound annual growth…
2025-2034 Financial Modeling Service Market Evolution: Disruptions, Innovations, …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Financial Modeling Service Market Through 2025?
Recent years have seen a significant surge in the market size of financial modelling services. The market, valued at $2.08 billion in 2024, is projected to climb to $2.36 billion in 2025, exhibiting a compound annual…
Fifth Generation (5G)-Powered Smart Stadiums Market Poised to Hit $22.73 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Fifth Generation (5G)-Powered Smart Stadiums Market Size Growth Forecast: What to Expect by 2025?
The market size of smart stadiums that utilize the fifth-generation (5G) technology has seen substantial growth over the past years. It is projected to increase from $6.07 billion in 2024 to $7.92 billion in 2025,…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
